Study on SSAO enzyme activity and anti-inflammatory effect of SSAO inhibitors in animal model of inflammation
- 21 December 2012
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 120 (6) , 963-967
Abstract
SSAO/VAP-1 participates in the accumulation of leukocytes at the site of inflammation. A new SSAO inhibitor, SzV-1287 was demonstrated to inhibit both acute and chronic inflammation in rats more effectively than the known enzyme inhibitor, LJP-1207. Surprisingly, the SSAO activity was not increased, but decreased both in acute and chronic inflammation. Though experiments are in progress to clarify these findings, the enzyme might play a role in the very early phase of inflammation and be inactivated during leukocyte extravasation.Keywords
This publication has 14 references indexed in Scilit:
- Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancerBlood, 2011
- Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrateBlood, 2009
- VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte ExtravasationArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Anti-Inflammatory Effects of Inhibiting the Amine Oxidase Activity of Semicarbazide-Sensitive Amine OxidaseThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Origins of Serum Semicarbazide-Sensitive Amine OxidaseCirculation Research, 2004
- Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1)Blood, 2004
- In Vivo Detection of Vascular Adhesion Protein-1 in Experimental InflammationThe American Journal of Pathology, 2000
- Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein‐1 (VAP‐1)European Journal of Immunology, 1996
- Induction and function of vascular adhesion protein-1 at sites of inflammation.Journal of Experimental Medicine, 1993
- Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetesDiabetes, 1993